tradingkey.logo

Neuropace Inc

NPCE
16.020USD
-0.170-1.05%
收盘 12/26, 16:00美东报价延迟15分钟
533.16M总市值
亏损市盈率 TTM

Neuropace Inc

16.020
-0.170-1.05%

关于 Neuropace Inc 公司

NeuroPace, Inc. is a medical device company. The Company is focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of debilitating seizures. Its novel and differentiated RNS System is a brain-responsive platform that delivers personalized, real-time treatment at the seizure source. The Company has developed its RNS System to address the individualized nature of drug-resistant epilepsy and deliver a safe therapy for focal onset seizures anywhere in the brain. The RNS System is a device that records brain activity data and allows clinicians to monitor patients not only in person, but also remotely. The RNS System monitors and analyzes the brain’s electrical activity, recognizes patient-specific abnormal patterns, and delivers treatment at the seizure source. The Company’s RNS System is also engaged in treating other brain disorders, including depression, impulse control disorders, memory disorders, and post-traumatic stress disorders.

Neuropace Inc简介

公司代码NPCE
公司名称Neuropace Inc
上市日期Apr 22, 2021
CEOBecker (Joel D)
员工数量184
证券类型Ordinary Share
年结日Apr 22
公司地址455 N. Bernardo Avenue
城市MOUNTAIN VIEW
上市交易所NASDAQ OMX - NASDAQ BASIC
国家United States of America
邮编94043
电话16502372700
网址https://www.neuropace.com/
公司代码NPCE
上市日期Apr 22, 2021
CEOBecker (Joel D)

Neuropace Inc公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
591.92K
+0.41%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
64.90K
-2.02%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
--
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
38.48K
+3.03%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
17.10K
+9.68%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
13.23K
+9.92%
Mr. R. Scott (Scott) Huennekens
Mr. R. Scott (Scott) Huennekens
Independent Director
Independent Director
--
--
Ms. Renee Ryan
Ms. Renee Ryan
Independent Director
Independent Director
--
--
Mr. Joel D. Becker
Mr. Joel D. Becker
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Lisa Andrade
Ms. Lisa Andrade
Independent Director
Independent Director
--
--
名称
名称/职务
职务
持股
持股变动
Mr. Frank M. Fischer
Mr. Frank M. Fischer
Independent Chairman of the Board
Independent Chairman of the Board
591.92K
+0.41%
Dr. Martha J. Morrell, M.D.
Dr. Martha J. Morrell, M.D.
Chief Medical Officer
Chief Medical Officer
64.90K
-2.02%
Mr. Patrick F. Williams
Mr. Patrick F. Williams
Chief Financial Officer
Chief Financial Officer
51.85K
--
Mr. Joseph S. (Joe) Lacob
Mr. Joseph S. (Joe) Lacob
Independent Director
Independent Director
38.48K
+3.03%
Ms. Rakhi Kumar, CPA
Ms. Rakhi Kumar, CPA
Independent Director
Independent Director
17.10K
+9.68%
Dr. Uri Geiger
Dr. Uri Geiger
Independent Director
Independent Director
13.23K
+9.92%

收入明细

FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q1
FY2023
FY2022
FY2021
FY2020
FY2019
由于公司未披露,未能获取相关数据
地区USD
名称
营收
占比
United States
23.52M
0.00%
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 11月17日 周一
更新时间: 11月17日 周一
持股股东
股东类型
持股股东
持股股东
占比
Accelmed Growth Partners Management Ltd
13.40%
Polar Capital LLP
9.36%
Soleus Capital Management, L.P.
8.94%
OrbiMed Advisors, LLC
7.90%
Morgan Stanley & Co. LLC
7.67%
其他
52.72%
持股股东
持股股东
占比
Accelmed Growth Partners Management Ltd
13.40%
Polar Capital LLP
9.36%
Soleus Capital Management, L.P.
8.94%
OrbiMed Advisors, LLC
7.90%
Morgan Stanley & Co. LLC
7.67%
其他
52.72%
股东类型
持股股东
占比
Investment Advisor/Hedge Fund
26.09%
Private Equity
21.30%
Hedge Fund
19.37%
Investment Advisor
17.07%
Research Firm
8.41%
Individual Investor
2.71%
Pension Fund
0.29%
Bank and Trust
0.08%
Venture Capital
0.03%
其他
4.66%

机构持股

更新时间: 10月1日 周三
更新时间: 10月1日 周三
报告期
机构数
持股数
持股占比
持股变动
2025Q3
198
31.14M
94.13%
-2.95M
2025Q2
184
29.13M
88.81%
-1.17M
2025Q1
183
29.76M
92.98%
+2.27M
2024Q4
144
26.53M
86.07%
-49.99K
2024Q3
134
26.01M
86.62%
-1.02M
2024Q2
129
25.88M
90.53%
+502.69K
2024Q1
131
24.82M
87.55%
-513.24K
2023Q4
113
24.06M
92.70%
-1.70M
2023Q3
103
24.86M
97.20%
-1.10M
2023Q2
106
24.30M
96.22%
-2.15M
查看更多

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
Accelmed Growth Partners Management Ltd
4.43M
13.4%
--
--
Apr 09, 2025
Soleus Capital Management, L.P.
2.31M
6.99%
-295.21K
-11.32%
Jun 30, 2025
OrbiMed Advisors, LLC
2.61M
7.9%
-792.15K
-23.26%
Jun 30, 2025
Morgan Stanley & Co. LLC
2.58M
7.79%
+52.63K
+2.08%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
1.54M
4.64%
+803.81K
+109.91%
Jun 30, 2025
The Vanguard Group, Inc.
1.37M
4.14%
+171.20K
+14.29%
Jun 30, 2025
First Light Asset Management, LLC
1.38M
4.17%
-203.64K
-12.86%
Jun 30, 2025
Armistice Capital LLC
1.15M
3.48%
-1.28K
-0.11%
Jun 30, 2025
Kent Lake PR LLC
925.00K
2.8%
-25.00K
-2.63%
Jun 30, 2025
查看更多

持股ETF

更新时间: 12月6日 周六
更新时间: 12月6日 周六
机构名称
占比
iShares Neuroscience and Healthcare ETF
0.64%
Principal U.S. Small-Cap ETF
0.05%
iShares Micro-Cap ETF
0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 2000 Growth ETF
0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
0.01%
Proshares Ultra Russell 2000
0.01%
查看更多
iShares Neuroscience and Healthcare ETF
占比0.64%
Principal U.S. Small-Cap ETF
占比0.05%
iShares Micro-Cap ETF
占比0.05%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
占比0.02%
ProShares Hedge Replication ETF
占比0.02%
ProShares UltraPro Russell2000
占比0.01%
iShares Russell 2000 ETF
占比0.01%
iShares Russell 2000 Growth ETF
占比0.01%
Invesco Russell 2000 Dynamic Multifactor ETF
占比0.01%
Proshares Ultra Russell 2000
占比0.01%

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
类型
比率
暂无数据
公告日期
类型
比率
暂无数据

常见问题

Neuropace Inc的前五大股东是谁?

Neuropace Inc 的前五大股东如下:
Accelmed Growth Partners Management Ltd持有股份:4.43M,占总股份比例:13.40%。
Soleus Capital Management, L.P.持有股份:2.31M,占总股份比例:6.99%。
OrbiMed Advisors, LLC持有股份:2.61M,占总股份比例:7.90%。
Morgan Stanley & Co. LLC持有股份:2.58M,占总股份比例:7.79%。
BlackRock Institutional Trust Company, N.A.持有股份:1.54M,占总股份比例:4.64%。

Neuropace Inc的前三大股东类型是什么?

Neuropace Inc 的前三大股东类型分别是:
Accelmed Growth Partners Management Ltd
Polar Capital LLP
Soleus Capital Management, L.P.

有多少机构持有Neuropace Inc(NPCE)的股份?

截至2025Q3,共有198家机构持有Neuropace Inc的股份,合计持有的股份价值约为31.14M,占公司总股份的94.13%。与2025Q2相比,机构持股有所增加,增幅为5.32%。

哪个业务部门对Neuropace Inc的收入贡献最大?

在FY2025Q2,--业务部门对Neuropace Inc的收入贡献最大,创收--,占总收入的--%。
KeyAI